| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/05/2009 | US20090062135 Methods for the identification of microrna and their applications in research and human health |
| 03/05/2009 | US20090062133 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
| 03/05/2009 | US20090061521 Recombinant negative strand RNA virus expression systems and vaccines |
| 03/05/2009 | US20090061520 Synthetic Biology Vectors |
| 03/05/2009 | US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/05/2009 | US20090061510 Vectors, eukaryotic cells |
| 03/05/2009 | US20090061502 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 03/05/2009 | US20090061498 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 03/05/2009 | US20090061488 Method of synthesizing a target polynucleotide encoding a protein |
| 03/05/2009 | US20090061487 Double-stranded RNA of about 19 to about 25 nucleotides in length capable of regulating gene expression by RNA interference; used as a therapeutic |
| 03/05/2009 | US20090061483 Acid fungal proteases |
| 03/05/2009 | US20090061482 Nucleotide sequences of coryneform bacteria coded for proteins participating in l-serine metabolism and method for microbial production of l-serine |
| 03/05/2009 | US20090061481 Highly-efficient hyperthermophilic dna ligase |
| 03/05/2009 | US20090061480 Nucleotide sequence encoding a modulator of nf-kb |
| 03/05/2009 | US20090061453 Methods and compositions for detecting colon cancers |
| 03/05/2009 | US20090061452 Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications |
| 03/05/2009 | US20090061444 Phytochrome-based fluorophores |
| 03/05/2009 | US20090061438 Detection of microsatellite instability and its use in diagnosis of tumors |
| 03/05/2009 | US20090061436 Peptide sequence that promotes tumor invasion |
| 03/05/2009 | US20090061431 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 03/05/2009 | US20090061427 Gene Encoding Protein Responsible for Flocculation Property of Yeast and Use Thereof |
| 03/05/2009 | US20090061420 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance |
| 03/05/2009 | US20090061152 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060987 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna |
| 03/05/2009 | US20090060954 Recombinant BCG Vaccine |
| 03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
| 03/05/2009 | US20090060951 Dna vaccine for koi herpes virus (khv) disease |
| 03/05/2009 | US20090060949 Flu vaccines and methods of use thereof |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060935 Amebiasis vaccine |
| 03/05/2009 | US20090060933 Proteases producing an altered immunogenic response and methods of making and using the same |
| 03/05/2009 | US20090060932 Immunizing an animal against Lyme disease by administering composition of at least two OspC polypeptides from Lyme Disease causing Borrelia comprising unlipidated and lipidated OspC polypeptides |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060927 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
| 03/05/2009 | US20090060916 Ligands that bind IL-4 and/or IL-13 |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060907 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 03/05/2009 | US20090060902 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060899 Composition of organic compounds |
| 03/05/2009 | US20090060896 Gene repair involving in vivo excision of targeting DNA |
| 03/05/2009 | US20090060889 Ii-RNAi involved Ii suppression in cancer immunotherapy |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060863 Derivatives of growth hormone and related proteins |
| 03/05/2009 | US20090057147 Devices and methods for biochip multiplexing |
| 03/05/2009 | CA2844647A1 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| 03/05/2009 | CA2735166A1 Compositions of asymmetric interfering rna and uses thereof |
| 03/05/2009 | CA2698146A1 Anti-epha2 antibody |
| 03/05/2009 | CA2698076A1 Metabolic regulators |
| 03/05/2009 | CA2697970A1 Rna antagonist compounds for the modulation of fabp4/ap2 |
| 03/05/2009 | CA2697953A1 Lmp of oilseed |
| 03/05/2009 | CA2697935A1 Pathogen control genes and methods of use in plants |
| 03/05/2009 | CA2697670A1 Method for production of carotenoid |
| 03/05/2009 | CA2697658A1 Transfection device utilizing sericin |
| 03/05/2009 | CA2697529A1 Receptor-targeting reagents |
| 03/05/2009 | CA2697517A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 03/05/2009 | CA2697513A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | CA2697512A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis |
| 03/05/2009 | CA2697498A1 Plasmid production and expression of recombinant proteins in cells cultivated without antibiotics |
| 03/05/2009 | CA2697480A1 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin |
| 03/05/2009 | CA2697448A1 Dendritic cell marker and uses thereof |
| 03/05/2009 | CA2696869A1 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease |
| 03/05/2009 | CA2696809A1 Method of increasing protein titres |
| 03/05/2009 | CA2695646A1 Plants with altered root architecture, related constructs and methods involving genes encoding nucleoside diphosphatase kinase (ndk) polypeptides and homologs thereof |
| 03/05/2009 | CA2693707A1 B7-dc variants |
| 03/05/2009 | CA2687026A1 Raccoon poxvirus expressing genes of porcine virus |
| 03/05/2009 | CA2685714A1 Inducible mutagenesis of target genes |
| 03/05/2009 | CA2684417A1 Plants having increased tolerance to heat stress |
| 03/05/2009 | CA2682704A1 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| 03/05/2009 | CA2679244A1 Nucleic acid compounds for inhibiting myc gene expression and uses thereof |
| 03/04/2009 | EP2031528A1 Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information |
| 03/04/2009 | EP2031395A1 Biomolecular substrate and test device |
| 03/04/2009 | EP2031076A1 Novel compositions and methods for cancer |
| 03/04/2009 | EP2031075A1 Molecular differences between species of the M. Tuberculosis complex |
| 03/04/2009 | EP2031074A1 Method of detecting variation and kit to be used therein |
| 03/04/2009 | EP2031069A1 Methods for stable transduction of cells with viral vectors |
| 03/04/2009 | EP2031068A1 Trap vector and gene trapping method by using the same |
| 03/04/2009 | EP2031067A1 Manufacture of genetically modified actinomycetes through recombination |
| 03/04/2009 | EP2031066A1 Mutant and gene encoding the same |
| 03/04/2009 | EP2031065A1 A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi |
| 03/04/2009 | EP2031064A1 Method for increasing protein titres |
| 03/04/2009 | EP2031063A2 Modulators of odorant receptors |
| 03/04/2009 | EP2031062A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 03/04/2009 | EP2031061A2 siDNA against influenza virus |
| 03/04/2009 | EP2031060A1 siDNA against influenza virus |
| 03/04/2009 | EP2031059A1 siDNA against hepatites C virus (HCV) |
| 03/04/2009 | EP2031058A1 Method of synthesizing polynucleotide |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 03/04/2009 | EP2031056A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 03/04/2009 | EP2031055A1 DNA molecule with insulator activity against chromosomal position effects in gene transfer processes in animal cells |
| 03/04/2009 | EP2031054A1 Fusion protein, gene related to fusion protein, vector, transformants, and anti-inflammatory medicinal composition |
| 03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
| 03/04/2009 | EP2030985A1 Transporter genes OATP-B, C, D, and E |
| 03/04/2009 | EP2030983A1 Insecticidal polypeptides and methods of use thereof |
| 03/04/2009 | EP2030628A1 A peptide for preventing or treating liver damage and its derivant and the use |
| 03/04/2009 | EP2030020A2 Aptamers directed to recombinant muc1 |